Chemed (NYSE:CHE) vs. Gaxos.ai (NASDAQ:GXAI) Head-To-Head Comparison

Gaxos.ai (NASDAQ:GXAI) and Chemed (NYSE:CHE) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Volatility and Risk

Gaxos.ai has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Chemed has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500.

Institutional & Insider Ownership

42.6% of Gaxos.ai shares are owned by institutional investors. Comparatively, 95.8% of Chemed shares are owned by institutional investors. 3.2% of Gaxos.ai shares are owned by insiders. Comparatively, 3.3% of Chemed shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Gaxos.ai and Chemed”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gaxos.ai	$6.01 million	1.07	-$3.90 million	($0.50)	-1.19
Chemed	$2.60 billion	2.50	$265.24 million	$19.91	24.89

Chemed has higher revenue and earnings than Gaxos.ai. Gaxos.ai is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Gaxos.ai and Chemed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Gaxos.ai	-64.81%	-38.79%	-36.99%
Chemed	10.60%	31.77%	18.90%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Gaxos.ai and Chemed, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gaxos.ai	1	0	0	0	1.00
Chemed	0	5	1	0	2.17

Chemed has a consensus price target of $530.75, suggesting a potential upside of 7.10%. Given Chemed’s stronger consensus rating and higher possible upside, analysts plainly believe Chemed is more favorable than Gaxos.ai.

Summary

Chemed beats Gaxos.ai on 13 of the 14 factors compared between the two stocks.

About Gaxos.ai

Gaxos.ai Inc. engages in developing artificial intelligence applications for various sectors. Its portfolio includes applications in mental and physical wellbeing, coaching, and gaming. In addition, it offers Gaxos, a gaming platform develop, design, acquire, and manage conventional games and combine these games with unconventional game mechanisms. The company was formerly known as The NFT Gaming Company, Inc. and changed its name to Gaxos.ai Inc. in January 2024. Gaxos.ai Inc. was incorporated in 2021 and is based in Roseland, New Jersey.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.